Moh A - Search Results

1

Reduced skeletal muscle mass to visceral fat area ratio is independently associated with reduced cognitive function in type 2 diabetes mellitus.

Low S, Ng TP, Goh KS, Moh A, Khoo J, Ang K, Yap P, Cheong CY, Tang WE, Lim Z, Subramaniam T, Sum CF, Lim SC. Low S, et al. Among authors: moh a. J Diabetes Complications. 2024 Feb;38(2):108672. doi: 10.1016/j.jdiacomp.2023.108672. Epub 2024 Jan 3. J Diabetes Complications. 2024. PMID: 38183854

2

Association between Plasma LRG1 and Lower Cognitive Function in Asians with Type 2 Diabetes Mellitus.

Low S, Moh A, Pandian B, Tan XL, Pek S, Zheng H, Ang K, Tang WE, Lim Z, Subramaniam T, Sum CF, Lim SC. Low S, et al. Among authors: moh a. J Clin Endocrinol Metab. 2024 Jan 3:dgad768. doi: 10.1210/clinem/dgad768. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38170213

3

Longitudinal profiling and tracking stability in the Singapore study of macro-angiopathy and microvascular reactivity in type 2 diabetes cohort.

Low S, Zheng H, Liu JJ, Moh A, Ang K, Tang WE, Lim Z, Subramaniam T, Sum CF, Lim SC. Low S, et al. Among authors: moh a. Diab Vasc Dis Res. 2023 Nov-Dec;20(6):14791641231218453. doi: 10.1177/14791641231218453. Diab Vasc Dis Res. 2023. PMID: 38059349 Free PMC article.

4

Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancer.

Viale G, Basik M, Niikura N, Tokunaga E, Brucker S, Penault-Llorca F, Hayashi N, Sohn J, Teixeira de Sousa R, Brufsky AM, O'Brien CS, Schmitt F, Higgins G, Varghese D, James GD, Moh A, Livingston A, de Giorgio-Miller V. Viale G, et al. Among authors: moh a. ESMO Open. 2023 Aug;8(4):101615. doi: 10.1016/j.esmoop.2023.101615. Epub 2023 Aug 8. ESMO Open. 2023. PMID: 37562195 Free PMC article.

5

Short-term Weight Trajectory of Severely Obese Individuals With and Without Pathogenic Satiety-Regulation Melanocortin 3/4 Receptor (MC3/4R) Mutations From a Multi-ethnic Asian Large Bariatric Surgery Program.

Lim JG, Moh A, Pandian B, Ubeynarayana CU, Lim NG, Tan BC, Ng D, Subramaniam T, Cheng A, Lim SC. Lim JG, et al. Among authors: moh a. J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231168108. doi: 10.1177/23247096231168108. J Investig Med High Impact Case Rep. 2023. PMID: 37070693 Free PMC article.

6

Triglyceride-glucose index is prospectively associated with chronic kidney disease progression in Type 2 diabetes - mediation by pigment epithelium-derived factor.

Low S, Pek S, Moh A, Ang K, Khoo J, Shao YM, Tang WE, Lim Z, Subramaniam T, Sum CF, Lim SC. Low S, et al. Among authors: moh a. Diab Vasc Dis Res. 2022 Jul-Aug;19(4):14791641221113784. doi: 10.1177/14791641221113784. Diab Vasc Dis Res. 2022. PMID: 35938490 Free PMC article.

7

Decline in skeletal muscle mass is associated with cognitive decline in type 2 diabetes mellitus.

Low S, Goh KS, Ng TP, Moh A, Ang SF, Khoo J, Ang K, Yap P, Cheong CY, Tang WE, Lim Z, Subramaniam T, Sum CF, Lim SC. Low S, et al. Among authors: moh a. J Diabetes Complications. 2022 Sep;36(9):108258. doi: 10.1016/j.jdiacomp.2022.108258. Epub 2022 Jul 18. J Diabetes Complications. 2022. PMID: 35905511

8

Association of early-onset Type 2 diabetes with cognitive impairment is partially mediated by increased pulse pressure.

Ang SF, Low SKM, Ng TP, Ang K, Yap PLK, Cheong CY, Lim Z, Tang WE, Moh AMC, Subramaniam T, Sum CF, Lim SC. Ang SF, et al. Among authors: moh amc. J Diabetes Complications. 2022 Jul;36(7):108209. doi: 10.1016/j.jdiacomp.2022.108209. Epub 2022 May 13. J Diabetes Complications. 2022. PMID: 35660335

9

Roux-en-Y gastric bypass versus best medical treatment for type 2 diabetes mellitus in adults with body mass index between 27 and 32 kg/m²: A 5-year randomized controlled trial.

Cheng A, Yeoh E, Moh A, Low S, Tan CH, Lam B, Sum CF, Subramaniam T, Lim SC. Cheng A, et al. Among authors: moh a. Diabetes Res Clin Pract. 2022 Jun;188:109900. doi: 10.1016/j.diabres.2022.109900. Epub 2022 May 2. Diabetes Res Clin Pract. 2022. PMID: 35513159 Clinical Trial.

10

Association Between Use of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors and Cognitive Function in a Longitudinal Study of Patients with Type 2 Diabetes.

Low S, Goh KS, Ng TP, Moh A, Ang SF, Wang J, Ang K, Tang WE, Lim Z, Subramaniam T, Sum CF, Lim SC. Low S, et al. Among authors: moh a. J Alzheimers Dis. 2022;87(2):635-642. doi: 10.3233/JAD-215678. J Alzheimers Dis. 2022. PMID: 35342091

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page